However, relative to somatic PLCs, the PLC isoform possesses a unique potency in stimulating Ca 2+ oscillations in eggs that is attributed to its novel biochemical characteristics.
Introduction
Oocyte (egg) activation is the first and most critical step that initiates embryo development after fertilisation. The term 'egg activation' describes a series of biochemical and morphological events that mammalian eggs go through to prepare the egg for early embryo development after sperm-egg fusion [1] . In all species examined up-to-date, the earliest signaling event in the activation of an egg by a sperm is a large transient increase in the level of intracellular free calcium (Ca 2+ ) concentration [1] [2] [3] . In many non-mammalian species (such as frogs and sea urchins), the Ca 2+ increase entails a single rise (one spike).
Contrastingly, in mammals and ascidians the Ca 2+ signal is delivered as a prolonged sequence of repetitive Ca 2+ transients, known as Ca 2+ oscillations, that start soon after gamete fusion, persisting for several hours and beyond the completion of meiosis [1, 2, [4] [5] [6] . The frequency and duration of Ca 2+ oscillations appears to be relatively species-specific, ranging from every two minutes, to every hour [1, 7, 8] . This striking phenomenon consequently orchestrates a series of further events of egg activation, such as cortical granule exocytosis (CGE), which blocks polyspermy, meiotic resumption, and pronuclear development [1, 9, 10] . Mammalian eggs are very sensitive to the precise pattern of Ca 2+ oscillations [11, 12] . The frequency and amplitude of Ca 2+ oscillations are directly responsible for cell cycle progression, with varying Ca 2+ transients resulting in different rates of cell cycle progression [13, 14] . Considering that the rate of cell cycle progression of human oocytes following fertilization has been postulated as an indicator of normal embryogenesis [15] , the profile of Ca 2+ oscillations during mammalian fertilisation may not only be necessary and sufficient for egg activation to occur but also equally important for subsequent embryogenic events [16] .
Several lines of evidence suggest that the generation of Ca 2+ oscillations in mammalian eggs is a direct consequence of inositol 1,4,5-trisphosphate (InsP 3 )-mediated Ca 2+ release [1, 4, 17] . The involvement of the universal Ca oscillations and egg activation [18] [19] [20] . Furthermore, microinjection of InsP 3 or adenophostin A, an InsP 3 analogue, lead to Ca 2+ oscillations in all mammalian eggs examined, demonstrating the necessity of this signaling pathway in progression of the Ca 2+ release and egg activation process at mammalian fertilisation [1, 21, 22 ].
Sperm factor hypothesis and a novel PLC as the trigger of Ca 2+ oscillations at fertilisation
The vigorously-contested scientific debate over the precise mechanism of how a single sperm elicits the generation of Ca 2+ oscillations in the unfertilized egg dates over several decades. Many theories had been proposed to explain the genesis of the Ca 2+ transients that successfully trigger egg activation during mammalian fertilisation (for review see [1] ). Over the years, the weight of evidence has steadily shifted significantly in support of the 'sperm factor' hypothesis as the most appropriate model for egg activation in mammalian, and a number of marine invertebrate, species. This theory proposed that the sperm contains a soluble factor that, upon sperm-egg fusion, readily diffuses into the egg, and is functionally capable of triggering Ca 2+ release from intracellular stores [5] . Experimental support for this hypothesis came from studies demonstrating that injection of sperm cytosolic extracts into mammalian eggs triggered a prolonged series of Ca 2+ oscillations, indistinguishable to those seen at fertilisation, and this physiological stimulus initated all the necessary events for successful egg activation [5, 23] [4, [37] [38] [39] [40] , while nonmammalian testis-specific PLC homologues have been identified in the chicken [41] and fish [42, 43] . Additional support for the fundamental role of PLC at mammalian fertilisation came from a number of genetic and clinical reports that directly linked certain types of human male infertility with PLC deficiencies (abnormally low expression levels or mutated forms of PLC) in the sperm of IVF patient couples presenting with oocyte activation deficiencies (OAD) and thus total fertilisation failure i.e. infertility [44] [45] [46] [47] [48] [49] .
It is now well characterised and widely believed that upon sperm-egg membrane fusion, PLC is delivered from the sperm head into the egg cytoplasm and this then catalyses 
PLC structure and domain organization
Mammalian phosphoinositide-specific phospholipase C (PI-PLC) comprises a family of ubiquitous intracellular enzymes that play an essential role in activating intracellular signal transduction pathways to regulate various cellular functions [4, 62] . Mutagenesis of conserved active site residues within the XY catalytic domain of PLC resulted in loss of enzymatic activity, and thus its inability to induce Ca 2+ release in mammalian eggs [1, 50] . In all PLC isoforms, a discrete region separates the X and Y catalytic domains, known as the XY-linker. In PLC, this is an unstructured linker region with a distinctive cluster of basic amino acid residues not found in the XY-linker regions of the other PLC isoforms, and playing an important regulatory role in PLC function [1, 34, 50] .
A notable structural difference of sperm PLC to somatic PLC isoforms is it's lack of a pleckstrin homology (PH) domain [34] . PH domains are well defined structural modules of ~120 amino acid residues long, which have been identified in more than 100 different proteins [1, 4] . All PLC isoforms except PLC and PLC possess a PH domain. It is believed that the PH domain facilitates the binding of PLCs to biological membranes [62, 65] . The PH domain of PLC1 mediates the binding of this enzyme to the cell plasma membrane by its high-affinity and -specificity binding to its membrane-bound substrate, PIP 2 [66] . With the significant absence of a PH domain, PLC is most closely related in domain structure to PLC1 enzyme exhibiting a 33% identity and 47% similarity [34] . Due to the lack of a PH domain, PLC appears to employ a unique mechanism to target it's biological membrane substrate, involving synergy of the positively-charged N-terminal lobe EF-hand domain with the basic amino acids at the C-terminal end of its XY-linker region, that coalesce through electrostatic interactions with its negatively-charged substrate, PIP 2 [67] [68] [69] .
Essential role of the EF hand domains in the Ca 2+ sensitivity and membrane targeting of PLC
Arguably the most critical physiological feature of PLC allowing it to be enzymatically very active in mammalian eggs relative to other somatic PLCs, is its uniquely high Ca 2+ sensitivity [35, 70] . PLC is 100-fold more Ca 2+ sensitive compared with its PLC1
counterpart, displaying an EC 50 of 80nM [70] , well within the range of reported resting Ca 2+ concentrations in mammalian eggs, ~120nM, explaining why PLC's biochemical activity is observed very soon after its release from the sperm into the egg cytoplasm [70] .
We have previously shown that deletion of the EF-hand domains dramatically increases the EC 50 of PLC from 80nM to 30M [70] , while replacement of PLC EFhand domains with that from PLC1 results in a 10-fold decrease in the Ca 2+ sensitivity of PLC, without significantly affecting its enzymatic activity [71] . In addition, in parallel with our empirical data, mathematical modelling approaches have strongly suggested that the EFhand motifs are the major determinants of the high Ca 2+ sensitivity of PLC, which in turn leads to its unsurpassed effectiveness in triggering high frequency Ca 2+ oscillations in mammalian eggs [71] .
Recently, we investigated whether replacement of the EF-hand domains of rat PLC1 with mouse PLC, in a PLC1 construct lacking the PH domain can confer to this chimeric enzyme the high Ca 2+ sensitivity of PLC. We generated the PH/PLC1/EF construct, as shown in Figure 2A comprising the N-terminal 150 aa of PLC (containing its EF-hand domains) fused to a PLC1 deletion construct lacking the first 284 aa (comprising both its PH & EF-hand domain regions). This PH/PLC1/EF construct encodes a 624 aa chimaeric protein that was expressed using the pETMM60 vector and isolated by affinity chromatography as previously described [69, [71] [72] [73] were in good agreement with those obtained at previous studies [70, 72, 73] , while the EC 50
for PH/PLC1/EF (4.71 M) was slightly lower compared to PLC1, but 64-fold higher compared to the EC 50 of PLC. Our experiments suggest that the EF-domains of PLC on their own are not sufficient to confer the high Ca 2+ sensitivity of PLC to a PLC1-like protein lacking the PH domain, indicating that the EF-domains play a vital role in conferring the high Ca 2+ sensitivity of PLC but the overall PLC protein tertiary structure is an additional essential requirement.
Interestingly, the N-terminal lobe of the EF-hand domains of PLC contains a cluster of basic amino acid residues. We recently demonstrated that sequential neutralisation of these basic residues within the first EF-hand domain of PLC significantly diminishes the PIP 2 -binding properties of PLC [69] . We surmised that PIP 2 might be attracted to the negativelycharged PIP 2 -containing component of the intracellular vesicular membrane through electrostatic interactions and thus, both the EF-hand and the XY-linker regions which are rich in basic residues, are essential for this interaction. This molecular interaction provides a tether that facilitates proper PIP 2 substrate access to and binding with the PLC active site [69] .
The regulatory role of the non-conserved XY-linker region
The XY-linker region of PLC is extended in length and contains more positivelycharged amino acid residues relative to its PLC1 counterpart [34, 50] . Notably, the XYlinker is the most non-conserved region of the PLC domain sequences determined from different species, but in all cases this linker region contains a number of positively-charged residues in close proximity to the Y catalytic domain [4, 50] . The specific physiological rationale for this XY-linker diversity is still unclear. Perhaps the diversity in this sequence may explain the species-specific differences in specific patterns of Ca 2+ oscillations observed for various mammalian PLC enzymes, as well as the divergent relative potencies of these enzymes in triggering cytosolic Ca 2+ oscillations when expressed in mouse eggs [4, 6] .
Notably, we have demonstrated that the XY-linker plays a key role in the functional regulation of PLC enzyme activity and also in its important ability to contribute to the interaction with its membrane-resident lipid substrate, PIP 2 [67, 68, 74] , Finally, the XYlinker region contains a predicted nuclear localization signal (NLS) sequence that may play a role in the regulation of at least mouse PLC [75] .
The vital role of PLC C2 domain is highlighted by male infertility-linked point mutation
All PLC isoforms possess a C2 domain, following the XY catalytic domain. These domains comprise 120 amino acid residues and play an important role in the Ca 2+ -dependent subcellular membrane targeting of several lipid-metabolizing enzymes, such as PLC1 and cPLCA2 [76] . In PLC1, the structurally closest protein to PLC, the C2 domain interacts with the membrane phospholipid, phosphatidylserine (PS) to form a C2-Ca 2+ -phosphatidylserine quaternary complex, which enhances its enzymatic activity [77] . [70, 71] . These observations suggest a disparate, vital (but apparently non-hydrolytic) role of the C2 domain in PLC function. Further support for this suggestion came from the identification of a male infertility-linked point mutation located in the C2 domain of PLC [49] . This is the first PLC infertility-linked mutation to be reported in a domain other than the XY catalytic domain. In this mutant, an isoleucine (I) residue is substituted with a phenylalanine (F) residue in 489 position (I489F) of human PLC sequence [49] . Analysis of this mutation revealed that at physiological concentrations this PLC mutant is unable to trigger Ca 2+ release in mouse eggs [79] . However, microinjection of non-physiological levels could rescue the infertile phenotype, leading to Ca 2+ oscillations and egg activation. Further biochemical characterization suggested that the I489F had no effect on the enzymatic properties of PLC, but dramatically reduced its in vitro binding to PI(3)P-and PI(5)Pcontaining liposomes [79] . These findings highlight the critical role of this domain in PLC function due to its novel membrane binding/localisatio characteristics (Figure 4 ). Further investigation is required to delineate the physiological significance of PLC-PI(3)P and -PI(5)P interactions and to identify other potential egg-derived binding partners of this domain that might regulate PLC function within the egg.
Localisation of PLC in the sperm
PLC has been identified in sperm of numerous species and generally appears localised at distinct subcellular regions of the sperm head, with potentially differential functional roles for each specific population [64] . PLC has been identified in acrosomal and post-acrosomal regions of mouse and porcine sperm, with a tail population also identified in porcine sperm [80] [81] [82] . In equine sperm, PLC was reported in the acrosome, equatorial segment, head mid-peace, as well as the principal piece of the flagellum [40] . In humans, three distinct populations of PLC have been identified in the acrosomal, equatorial and postacrosomal regions of the sperm head, with a potentially additional tail localisation [44, 47, [83] [84] [85] [86] . However, it remains unclear whether such populations are physiologically valid.
Specific PLC localisation remains a concern, with numerous studies identifying variable patterns within the same mammalian species, often using the same antibody probe.
A previous study suggested that PLC was localised within the acrosome of mouse and human sperm, with further PLC populations present on the sperm surface [87].
However, using the same antibodies, multiple studies indicated PLC localisation to the postacrosomal region of the mouse sperm [80, 88] , as well as to the acrosomal, equatorial, and post-acrosomal regions of human sperm [44, [84] [85] [86] 89] . Indeed, there only seems to be consensus regarding PLC localisation in mouse sperm. This variance in PLC localisation is not only limited to observations between different species, with a study reporting significant variance in localisation patterns observed in sperm between human subjects [86] .
Perhaps such variance is attributable to differences in immunolocalisation protocols While such results remain supportive of PLC's proposed identity as the mammalian sperm factor, it is important that further high-resolution localisation analysis enables a concensus view to emerge.
Localisation of PLC in the egg and the search for a putative 'egg factor'
Another unique biochemical feature of sperm PLC is its localisation in mammalian eggs. Somatic PLC isoforms are known to localise to the plasma membrane where they hydrolyse their membrane-bound substrate PIP 2 [50] . However, there is no detectable PLC localisation in the plasma membrane of eggs [93] . Moreover, the depletion of plasma membrane PIP 2 using a targeted inositol lipid phosphatase has no effect upon PLC-or Importantly, morphologically normal sperm from several human patients have been found to fail to activate mouse eggs [45, 101] , with sperm either unable to elicit Ca 2+ release following injection into mouse eggs, or else producing significantly diminished and abnormal Ca 2+ oscillation profiles, being severely reduced in frequency and amplitude [44, 45] .
Furthermore, immunofluorescence and immunoblot analysis of such sperm exhibited reduced or absent levels of PLC within the sperm head, while the Ca 2+ oscillation-inducing activity of such sperm was 'rescued' in mouse oocytes by the co-injection of PLC cRNA [44, 45] .
Subsequent to these studies, numerous investigations performing PLC assessment in human sperm undergoing fertility treatment indicate that sperm with defective oocyte activation capacity are associated with reduced/absent levels of PLC [44-46, 86, 102, 103] , while PLC deficiencies are also associated with sperm conditions, such as globozoospermia [45, 46, 102, 104, 105] and recurrent partial hydatidiform moles (abnormal pregnancies) [106] .
Importantly, abrogation of PLC gene function in patients diagnosed with oocyte activation deficiency has also now been reported. Two PLC mutations were identified from an infertile man, whose sperm lacked the capacity to elicit Ca 2+ oscillations that led to disrupted PLC activity and an infertility phenotype [45, 47] . Biochemical characterisation indicated that the mutations, both occurring in the active site domains of PLC, led to disruption of local protein folding, while injection of correspondingly mutated cRNA and recombinant protein into mouse eggs resulted in highly abnormal Ca 2+ transients that were unable to initiate oocyte activation [48, 90, 107] . Both mutations were reported to be heterozygous, with one inherited from the patient's father, with the other inherited from the patient's mother, indicating for the first time that such maternally-inherited loss-of-activity mutations contribute towards male infertility [47, 107] .
Subsequently, a homozygous mutation was identified by Escoffier et al., (2016) from a similarly infertile patient, occurring within the C2 domain of PLC [49] . As discussed above, this PLC C2 domain mutant displays similar enzymatic activity compared to wildtype PLC, however exhibiting dramatically reduced binding to PI(3)P and PI(5)P-containing liposomes [79] . Single nucleotide polymorphisms (SNPs) have also been reported either within the coding sequence of PLC or its associated bi-directional promoter in human patients [44, 108] . Further polymorphisms have also been identified in the PLC gene of bulls and stallions, at promoter regions and exonic loci, which were shown to positively correlate to semen parameters and the fertility status of such sperm [109, 110] . However, as these polymorphisms were not physiologically or biochemically characterised, any potential contributory effects exerted by SNPs upon sperm PLC function are currently unclear.
Recent data suggest a significant level of variance in terms of total PLC levels and localisation patterns in human sperm from normal, fertile men [44, 45, 84, 85] . Such variance in sperm PLC presents an interesting problem, particularly when considering that absent/reduced levels of PLC have previously been implicated in cases of infertility, and that levels of PLC directly impact upon the frequency and amplitude of the resulting Ca 2+ oscillations. Injection of increasing PLC cRNA levels in human oocytes results in increasing frequencies and amplitudes of Ca 2+ oscillations [111] , which may also exert effects upon gene expression profiles in a Ca 2+ -dependent manner during early embryogenesis [13, 14] . Indeed, preimplantation development of oocytes activated by differential levels of human PLC suggests that too little, or too much, PLC leads to poor development to the blastocyst stage despite apparently normal oocyte activation. Thus, abnormalities in sperm PLC levels may underlie not only infertility through fertilisation failure, but also cases of male sub-fertility, whereby adequate PLC may be delivered to oocytes to cause activation only, but which may be insufficient for embryonic competence.
Clinical applications of PLC
The success of ART is reflected by estimates that such methods now account for ~7% of total birth rates in some developing countries [46] . However, several conditions such as severe male infertility (19-57% of infertility cases) remain untreatable, even after ICSI treatment [112] . It seems clear that sperm from males that fail to activate human eggs following ICSI exhibit abrogated, reduced, or aberrant forms of PLC. Thus, alongside a potential diagnostic parameter, PLC may represent an endogenous method to clinically treat cases of egg activation failure.
Currently, oocyte activation failure is clinically treated by assisted oocyte activation (AOA) methods, predominantly application of Ca 2+ ionophores, resulting in improved rates of fertilization and successful pregnancy. However, concerns currently exist that such synthetic non-native chemicals may be potentially detrimental to embryo viability [113] , considering that such methods elicit a single large Ca 2+ increase unlike the repetitive pattern of Ca 2+ oscillations observed at fertilisation. Indeed, computational modelling and experimental studies suggest that the temporal pattern of Ca 2+ changes may exert specific effects upon rates of cell cycle progression, and thus, subsequent embryogenesis [114] . Thus, it is important that an endogenous, potentially safer method of assisted egg activation is established, for which PLC is an extremely attractive candidate. Rogers et al. [115] obtained parthenogenetically-generated human blastocysts by injection of PLC cRNA into eggs, while Yoon et al. [44] demonstrated that abnormalities in sperm PLC could be counteracted by co-injection with mouse PLC cRNA. Moreover, a very recent study reported the determination of the optimal concentration of human PLC cRNA to activate human oocytes [111] .
However, while representing a significant research tool, clinical use of cRNA injections may prove problematic due to uncontrolled expression and potential reverse transcription activity inherent to mammalian oocytes [46] . Thus, the production of purified, enzymatically-active, recombinant human PLC protein has been a goal for many laboratories around the world, to enable dose-controlled delivery of functionally-viable PLC protein.
To this degree, recent efforts have been able to produce such versions of human PLC, which is able to effectively rescue activation in mouse and human oocytes, representing a significant milestone in potential clinical applicability to reproductive medicine [90] . However, while this recombinant protein may be significantly advantageous to patients suffering from recurrent ICSI failure, it remains unclear whether a PLC 'therapeutic' may be able to aid further types of patients where normal activation at fertilisation occurs, but subsequent initiation of early embryogenesis is poor, a causative factor for recurrent implantation failure.
Concluding remarks
The 2002 discovery of PLC, the putative physiological 'sperm factor' that plays a vital role at mammalian fertilisation represented a major breakthrough in the field of reproductive biology. It is now widely accepted that PLC is the sole physiological stimulus that is delivered from the fertilising sperm into the egg cytoplasm, soon after sperm-egg 
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The authors declare no financial interests. -dependence for PIP 2 hydrolysis, determined by non-linear regression analysis (GraphPad Prism 5), (see Fig. 3 ) for PLC, PLC1 and PH/PLC1/EF fusion proteins. Table 1 ). 
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